Raymond James & Associates’s Silver Standard Resources SSRI Stock Holding History

Raymond James & Associates’s Portfolio SSRI Stock Details SSRI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q3	–	Sell	-11,366	Closed	-$110K	–	3579
2017 Q2	$110K	Buy	+11,366	New	+$114K	﹤0.01%	3099
2016 Q4	–	Sell	-11,266	Closed	-$136K	–	3477
2016 Q3	$136K	Sell	11,266 -3,294	-23%	-$44.4K	﹤0.01%	2950
2016 Q2	$189K	Buy	+14,560	New	+$135K	﹤0.01%	2675

Other funds holding SSRI

SCP

Syntal Capital Partners Midland, Texas $10M AUM 35.51% 1-Year Est. Return

Raymond James & Associates's SSRI Position: Q3 2017 in Review

Raymond James & Associates sold out of Silver Standard Resources (SSRI) in Q3 2017, closing a stake of 11,366 shares — an estimated $110K sold.

Raymond James & Associates first reported a position in SSRI in Q2 2016 and held it in 3 quarters. The position peaked at $189K in Q2 2016. 1 fund tracked by Wall St. Rank holds SSRI as of Q3 2017.

Raymond James & Associates reported no remaining Silver Standard Resources position as of Q3 2017 after selling out during the quarter.
Raymond James & Associates sold 11,366 Silver Standard Resources shares in Q3 2017, an estimated $110K.
Raymond James & Associates first reported a position in Silver Standard Resources in Q2 2016 and held it in 3 quarters.
Raymond James & Associates's Silver Standard Resources position peaked at $189K in Q2 2016.
1 fund tracked by Wall St. Rank held Silver Standard Resources as of Q3 2017.

Based on Raymond James & Associates's 13F filing for Q3 2017, filed 13 Nov 2017.